Literature DB >> 3621449

Reduction of vincristine toxicity by Cronassial.

K Hellmann, G E Hutchinson, K Henry.   

Abstract

A mixture of gangliosides (Cronassial) protects against the chronic but not the acute lethal toxicity of vincristine in mice and affords some protection against the acute lethal toxicity of vincristine in chicks. The protective effect of Cronassial appears to be greatest near the LD50 of vincristine and then diminishes as the dose of vincristine increases further. Cronassial does not, however, reduce the vincristine antitumour activity, so that the net effect is an improvement in the vincristine therapeutic index. Clinical trials are underway to examine the effect of the combination on the development of neurotoxicity in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621449     DOI: 10.1007/bf00252954

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  4 in total

1.  CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES.

Authors:  L SVENNERHOLM
Journal:  J Neurochem       Date:  1963-09       Impact factor: 5.372

2.  Neurotoxicity of antineoplastic drugs.

Authors:  R S Kaplan; P H Wiernik
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

3.  Glutamic acid modification of vincristine toxicity.

Authors:  D V Jackson; D L Rosenbaum; L J Carlisle; T R Long; H B Wells; C L Spurr
Journal:  Cancer Biochem Biophys       Date:  1984-09

4.  Clinical trial of folinic acid to reduce vincristine neurotoxicity.

Authors:  D V Jackson; R A McMahan; E K Pope; L D Case; M R Cooper; M K Kaplon; F Richards; J J Stuart; D R White; P J Zekan
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  4 in total
  4 in total

1.  Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.

Authors:  L Facci; S D Skaper; D Presti; G Kirschner; A Leon; L Chieco-Bianchi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

2.  Effect of high dose mitozantrone with Cronassial on the Lewis lung carcinoma and L1210 leukaemia.

Authors:  K Hellmann; G E Hutchinson; K Henry
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

3.  Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves.

Authors:  F Di Gregorio; G Favaro; C Panozzo; M G Fiori
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.

Authors:  Shaoyong Wu; Xiaohui Bai; Caixia Guo; Zhimei Huang; Handong Ouyang; Jingxiu Huang; Weian Zeng
Journal:  BMC Cancer       Date:  2021-11-02       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.